Top Cell and Gene Therapy Company in APAC
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Cell and Gene Therapy Company in APAC
Cell and Gene Therapy News
AI-Powered Morphology Analysis: Strengthening APAC Laboratory Diagnostics
Thursday, June 18, 2026
Healthcare systems across the Asia-Pacific (APAC) region are expanding investments in digital pathology, laboratory automation, and artificial intelligence to improve diagnostic capabilities and support growing testing demands. Hospitals, diagnostic laboratories, research institutions, and academic medical centers are adopting advanced technologies that enhance microscopic image analysis while improving workflow efficiency. Increasing testing volumes, greater demand for standardized laboratory practices, and the need for faster interpretation are encouraging broader use of AI-assisted analytical tools. How Is AI Improving Morphology Analysis Accuracy?
The Economic Impact of Cell and Gene Therapy Innovations
Friday, December 27, 2024
Cell and gene therapies can potentially remodel healthcare and significantly impact the global economy. Continued research and development and innovative manufacturing, delivery, and payment approaches will likely lead to a future where CGTs transform patients' lives worldwide. FREMONT CA: The CGT market is experiencing significant growth, driven by advancements in research and development, regulatory approvals, and increasing patient demand. Substantial investments from diverse sources underpin this expansion. Venture capital firms play a pivotal role by providing essential funding to biotech startups engaged in innovative CGT developm
Strategies for Equitable Access to Cell and Gene Therapies in Europe
Monday, February 19, 2024
With continued innovation, collaboration, and a commitment to equitable access, these groundbreaking therapies can reach the patients who need them most, transforming lives and healthcare landscapes across the continent. FREMONT, CA: Cell and gene therapies (CGTs) represent a groundbreaking paradigm shift in the field of medicine, presenting promising solutions for diseases that were previously deemed untreatable. These advanced therapeutic interventions entail the manipulation of a patient's cells or genes to combat various illnesses, particularly demonstrating significant potential in addressing conditions such as cancer, rare disease
